Interplay between histone deacetylases and autophagy--from cancer therapy to neurodegeneration.
about
Histone deacetylases in monocyte/macrophage development, activation and metabolism: refining HDAC targets for inflammatory and infectious diseasesHistone deacetylase 6 plays a role as a distinct regulator of diverse cellular processesHDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytesMalfolded protein structure and proteostasis in lung diseases.Histone deacetylase 6-mediated selective autophagy regulates COPD-associated cilia dysfunction.Disruption of autophagy by the histone deacetylase inhibitor MGCD0103 and its therapeutic implication in B-cell chronic lymphocytic leukemia.Vorinostat synergizes with ridaforolimus and abrogates the ridaforolimus-induced activation of AKT in synovial sarcoma cells.Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.Genetic variants of the autophagy pathway as prognostic indicators for prostate cancer.Estrogen receptor α regulates non-canonical autophagy that provides stress resistance to neuroblastoma and breast cancer cells and involves BAG3 functionHDAC6 and ovarian cancer.Sirtuins' modulation of autophagy.Autophagy in prostate cancer and androgen suppression therapy.Inclusion body formation, macroautophagy, and the role of HDAC6 in neurodegeneration.Autophagy and genomic integrity.Autophagy and transporter-based multi-drug resistance.Histone deacetylase inhibitors and cell death.Multiple system atrophy: genetic or epigenetic?Proteotoxicity and cardiac dysfunction.Protein aggregate formation in oligodendrocytes: tau and the cytoskeleton at the intersection of neuroprotection and neurodegeneration.The combination of irreversible EGFR TKIs and SAHA induces apoptosis and autophagy-mediated cell death to overcome acquired resistance in EGFR T790M-mutated lung cancer.Phenylbutyrate and β-cell function: contribution of histone deacetylases and ER stress inhibition.Autophagy regulating kinases as potential therapeutic targets for age-related macular degeneration.Epigenetics of Mucus Hypersecretion in Chronic Respiratory Diseases.ENC1 Modulates the Aggregation and Neurotoxicity of Mutant Huntingtin Through p62 Under ER Stress.HDACs and their inhibitors in immunology: teaching anticancer drugs new tricksThe Therapeutic Strategy of HDAC6 Inhibitors in Lymphoproliferative Disease
P2860
Q26768497-665D850D-2835-44AA-AF9F-01E15876A0AFQ26830233-673E42D7-B49D-4A81-9BF0-AE24200A4820Q28575023-3D6A4B82-028B-4D06-90DC-B58A47A8ADC5Q30353585-1D8AF317-DDF0-4F47-8AED-D6FA157ECCD1Q30559284-55A3279B-47DA-49D9-A984-810D9880F34BQ34038766-1A32B932-869A-4EF5-B127-1EDA4D7C7F86Q34587139-A702AAD7-8E19-44E2-9DB2-4291D84CCC7CQ35588352-78756D7D-0A2B-4DB8-A61C-8A3C864CADEFQ36056250-CBE183F0-BB80-401F-BA13-38EB21DA57C0Q36293853-5C390AE3-4C1A-480D-9002-219C1C8FDDAAQ36913610-8255DCEA-4056-4E84-9354-6584D12E728CQ38108575-D8BAE984-06CE-41E1-A7EC-DED0AF919758Q38112596-136A632E-5904-4DD5-A397-9F0932854101Q38126332-5C1374B7-0854-479A-971B-07DEE0098388Q38128164-9B0982B7-9FFC-43A6-9B0E-A832BEF8580BQ38202874-1A41EC0B-9630-4F82-8640-07D09B0A8FF7Q38217666-1F9C1B3B-51D4-4D06-97C1-854A1D1F98C8Q38303573-D51BB5B7-9510-4166-978E-99FAC50E2010Q38497014-F0DCBD36-483D-4E42-8DE0-40BD0DAB0E7BQ38530227-10521998-5A85-426D-8C63-82C3CD0E27A5Q38941593-328F41EB-B717-4932-9244-B2FB9A33243EQ39282297-AF9F6703-72FA-4675-B10B-588C5A53F599Q39512471-91BDCFF0-76E0-490A-B2A8-A6AC018FF397Q47725451-B04FD940-DB52-4C71-B994-6710490826D4Q53253751-9E4FEBFB-2ADD-44B0-84D1-510068573592Q57080833-D542D024-54C5-4EEC-99B0-DB16877FDE89Q58792448-43D5F94C-DA71-4407-94F7-7E8704091A1B
P2860
Interplay between histone deacetylases and autophagy--from cancer therapy to neurodegeneration.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Interplay between histone deac ...... therapy to neurodegeneration.
@en
Interplay between histone deac ...... therapy to neurodegeneration.
@nl
type
label
Interplay between histone deac ...... therapy to neurodegeneration.
@en
Interplay between histone deac ...... therapy to neurodegeneration.
@nl
prefLabel
Interplay between histone deac ...... therapy to neurodegeneration.
@en
Interplay between histone deac ...... therapy to neurodegeneration.
@nl
P2860
P356
P1476
Interplay between histone deac ...... therapy to neurodegeneration.
@en
P2093
Oliver Trüe
Patrick Matthias
P2860
P356
10.1038/ICB.2011.103
P577
2011-11-29T00:00:00Z